Companies with a Health score of at least 4, ordered by Health score.
Novoheart Holdings Inc. operates as a stem cell biotechnology company in the United States.
Telo Genomics Corp., a precision medicine company, focuses on the development and commercialization of predictive technological products.
BioSyent Inc., a specialty pharmaceutical company, through its subsidiaries, sources, acquires or in-licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in the United States.
InMed Pharmaceuticals Inc., a pre-clinical stage biopharmaceutical company, researches and develops cannabinoid-based therapies.
InnoCan Pharma Corporation focuses on the development and sale of cannabidiol integrated pharmaceuticals in Israel.
Eastwood Bio-Medical Canada Inc. researches and develops natural health products in North America and Asia.
Vinergy Cannabis Capital Inc. develops cannabis products using pharmaceutical formulation techniques to produce dosage forms for human use.
SpeakEasy Cannabis Club Ltd. produces medical cannabis in Canada.
Ignite International Brands, Ltd., an investment company, focuses on seeking investment opportunities in the global cannabis sector.
Ventura Cannabis and Wellness Corp. operates as a vertically integrated, California-based cannabis product company.
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops novel therapeutics for the treatment of chronic cough and other hypersensitization disorders.
Matica Enterprises Inc. engages in the medical marijuana business.
Cultivar Holdings Inc. operates in the cannabis space.
Medicure Inc., a pharmaceutical company, engages in the development and commercialization of therapies for the cardiovascular market in the United States.
ESSA Pharma Inc., a pharmaceutical company, focuses on the development of small molecule drugs for the treatment of prostate cancer.
